Improved Survival in Surgically Resected Distal Cholangiocarcinoma Treated with Adjuvant Therapy: a Propensity Score Matched Analysis

[1]  D. Fraker,et al.  Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis , 2017, Annals of Surgical Oncology.

[2]  E. Assenat,et al.  Gemox versus surveillance following surgery of localized biliary tract cancer: Results of the PRODIGE 12-ACCORD 18 (UNICANCER GI) phase III trial. , 2017 .

[3]  M. Nagino,et al.  Recurrence after resection with curative intent for distal cholangiocarcinoma , 2017, The British journal of surgery.

[4]  Eva Ardanaz,et al.  Data Quality in Rare Cancers Registration: The Report of the RARECARE Data Quality Study , 2017, Tumori.

[5]  B. Blechacz.  Cholangiocarcinoma: Current Knowledge and New Developments , 2016, Gut and liver.

[6]  A. Radtke,et al.  Surgical Therapy of Cholangiocarcinoma , 2016, Visceral Medicine.

[7]  Jerome P. Reiter,et al.  A comparison of two methods of estimating propensity scores after multiple imputation , 2016, Statistical methods in medical research.

[8]  L. Dawson,et al.  Outcome of Adjuvant Therapy in Biliary Tract Cancers , 2015, American journal of clinical oncology.

[9]  D. Abbott,et al.  Adjuvant Chemotherapy and Radiation Therapy is Associated with Improved Survival for Patients with Extrahepatic Cholangiocarcinoma , 2015, Annals of Surgical Oncology.

[10]  Y. Murakami,et al.  Perineural Invasion in Extrahepatic Cholangiocarcinoma: Prognostic Impact and Treatment Strategies , 2013, Journal of Gastrointestinal Surgery.

[11]  D. Gouma,et al.  Survival analysis and prognostic nomogram for patients undergoing resection of extrahepatic cholangiocarcinoma. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  H. Ohge,et al.  Prognostic Factors After Surgical Resection for Intrahepatic, Hilar, and Distal Cholangiocarcinoma , 2011, Annals of Surgical Oncology.

[13]  Y. Murakami,et al.  Adjuvant Gemcitabine Plus S-1 Chemotherapy Improves Survival After Aggressive Surgical Resection for Advanced Biliary Carcinoma , 2009, Annals of surgery.

[14]  J. Everhart,et al.  Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas. , 2009, Gastroenterology.

[15]  S. van Buuren.  Multiple imputation of discrete and continuous data by fully conditional specification , 2007, Statistical methods in medical research.

[16]  Stef van Buuren,et al.  Multiple imputation of discrete and continuous data by fully conditional specification , 2007 .

[17]  Steven C Cunningham,et al.  Cholangiocarcinoma: Thirty-one-Year Experience With 564 Patients at a Single Institution , 2007, Annals of surgery.

[18]  E. Hatano,et al.  Surgical Resection of Hilar Cholangiocarcinoma: Analysis of Survival and Postoperative Complications , 2007, World Journal of Surgery.

[19]  D. Gouma,et al.  Improved Outcome of Resection of Hilar Cholangiocarcinoma (Klatskin Tumor) , 2006, Annals of Surgical Oncology.

[20]  Jin‐Young Jang,et al.  Actual Long-term Outcome of Extrahepatic Bile Duct Cancer After Surgical Resection , 2005, Annals of surgery.

[21]  M. D'Angelica,et al.  Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma , 2003, Cancer.

[22]  S. Kawasaki,et al.  Results of Surgical Resection for Patients With Hilar Bile Duct Cancer: Application of Extended Hepatectomy After Biliary Drainage and Hemihepatic Portal Vein Embolization , 2003, Annals of surgery.

[23]  U. Settmacher,et al.  Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality , 2003, Langenbeck's Archives of Surgery.

[24]  T. Takada,et al.  Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? , 2002, Cancer.

[25]  M. Gonen,et al.  Staging, Resectability, and Outcome in 225 Patients With Hilar Cholangiocarcinoma , 2001, Annals of surgery.

[26]  K. Lillemoe,et al.  Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. , 1996, Annals of surgery.

[27]  C. Su,et al.  Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. , 1996, Annals of surgery.

[28]  D B Rubin,et al.  Multiple imputation in health-care databases: an overview and some applications. , 1991, Statistics in medicine.

[29]  P. Tushar,et al.   Intrahepatic, perihilar and distal cholangiocarcinoma: Management and outcomes. , 2017, Annals of hepatology.

[30]  Capecitabine Extends Survival for Biliary Tract Cancer. , 2017, Cancer discovery.

[31]  P. Tushar,et al.  Intrahepatic, Perihilar and Distal Cholangiocarcinoma: Management and Outcomes. , 2017, Annals of hepatology.

[32]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[33]  J. Klempnauer,et al.  What constitutes long term survival after surgery for hilar cholangiocarcinoma? , 1997, Cancer.

[34]  K. Lillemoe.  Current status of surgery for Klatskin tumors. , 1994, Current opinion in general surgery.

[35]  N. Dubrawsky.  Cancer statistics , 2022 .